INTECH Investment Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

INTECH Investment Management’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,970	Closed	-$211K	–	2580
2024 Q4	$211K	Buy	21,970 +5,811	+36%	+$30.3K	﹤0.01%	2008
2024 Q3	$46.2K	Buy	+16,159	New	+$50K	﹤0.01%	1988

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

INTECH Investment Management's PSTX Position: Q1 2025 in Review

INTECH Investment Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 21,970 shares — an estimated $211K sold.

INTECH Investment Management first reported a position in PSTX in Q3 2024 and held it in 2 quarters. The position peaked at $211K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

INTECH Investment Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
INTECH Investment Management sold 21,970 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $211K.
INTECH Investment Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
INTECH Investment Management's Poseida Therapeutics, Inc. Common Stock position peaked at $211K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on INTECH Investment Management's 13F filing for Q1 2025, filed 20 May 2025.